Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How should we handle a customer complaint about the quality of a medicine?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q373 · Category H: Licensed operations and routine regulatory oversight (Q351–Q400)
Customer complaints are an important part of the Quality Management System and must be handled seriously and systematically. The standard process is as follows: 1. Record the details: regardless of the channel through which the complaint is received (telephone, email or in person), create a formal complaint record immediately, setting out in detail the complainant’s information, drug name, batch number and specific complaint (such as damaged packaging, unusual colour or foreign matter). 2. Initial assessment: a designated person (usually from the quality department) conducts an initial assessment of the seriousness of the complaint. If a potentially serious safety risk is involved, immediate quarantine of the relevant batch may need to be considered. 3. Investigation: investigate the complaint thoroughly. This may include checking retained samples from the same batch, reviewing production or distribution records, and interviewing relevant personnel to identify the root cause. 4. Take action and respond: take appropriate corrective and preventive action (CAPA) based on the investigation findings. A formal written response must also be provided to the customer within a reasonable time, setting out the investigation findings and the actions the company will take. The entire process must be fully documented.

📘 Regulatory basis

Both the Code of Practice for Licensed Wholesale Dealers and GMP guidance require licensees to establish written procedures for handling complaints, investigate and record all complaints, and take measures to prevent recurrence.

📗 Drew Tang's recommendations

Treat every complaint as a free opportunity for quality improvement. We recommend classifying and analysing trends across all complaints. For example, frequent complaints about damaged packaging for a particular product may indicate a need to review the packaging materials or transport process. Establishing a cross-departmental complaint investigation team can provide a more comprehensive analysis. A prompt, transparent and professional response to customers can sometimes turn a negative incident into an opportunity to build customer trust.

📕 Risk notice

Ignoring quality complaints or handling them improperly is a serious failure in the eyes of the regulatory authorities. If a customer escalates a complaint to the Department of Health after not receiving a satisfactory response, and you cannot provide complete internal investigation records, you will be in a very difficult position. If several complaints point to the same potential quality defect and you fail to identify and address it promptly, you may face more severe penalties if this leads to a serious incident such as a recall.

Back to Category H: Licensed Operations and Routine Oversight (Q351-Q400) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗